Morningstar US Small Growth Rating $13.91 0.00 (0.00%) As of 05/1/2026 Add Compare Share Share Ratings Stock AnalysisChartRatingsBuy This Stock Morningstar US Small Growth Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MSGR Aggregate RatingHold 2.36Holdings in MSGR have an aggregate rating of Hold based on 284 analyst ratings issued in the past year covering 20 companies (89.3% of the portfolio).MSGR Aggregate Price Target$13.91High Prediction$13.91Average Prediction$13.91Low Prediction$13.91Holdings in MSGR have an aggregate price target of $13.91 and a range of $13.91 to $13.91 covering 20 companies (89.3% of the portfolio).MSGR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce3 Reduce rating(s)Sell0 Sell rating(s)Strong Sell1 Strong Sell rating(s) Ratings for Stocks Held by Morningstar US Small Growth Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 20 MSGR Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.06%VRTXVertex Pharmaceuticals$424.36-1.3%4.6004 of 5 stars2.83$554.83 30.7%29Trending NewsEarnings ReportAnalyst DowngradeInsider Trade7.99%SCLXScilex$10.73-3.8%1.0359 of 5 stars1.001News CoverageAnalyst DowngradeGap UpHigh Trading Volume7.01%ARCTArcturus Therapeutics$8.41-1.9%2.4937 of 5 stars2.69$29.50 250.8%13Upcoming Earnings6.62%ALNYAlnylam Pharmaceuticals$301.11+1.1%4.3421 of 5 stars2.81$471.96 56.7%26Earnings ReportAnalyst Upgrade6.44%MRNAModerna$46.71-1.2%1.1361 of 5 stars1.84$35.73 -23.5%19Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst Revision6.17%BNTXBioNTech$95.50-3.9%4.1053 of 5 stars2.72$133.13 39.4%18News CoveragePositive NewsEarnings ReportGap Down5.97%SRPTSarepta Therapeutics$21.79-1.1%3.1881 of 5 stars2.11$32.63 49.7%28Upcoming Earnings5.78%PTCTPTC Therapeutics$65.04-0.7%3.8059 of 5 stars2.63$84.40 29.8%16News CoverageUpcoming Earnings4.94%MRVIMaravai LifeSciences$3.85+1.6%2.2863 of 5 stars2.40$5.38 39.6%5Upcoming Earnings4.29%NTLAIntellia Therapeutics$13.31-4.0%2.8209 of 5 stars2.35$20.09 50.9%23Analyst RevisionGap Up4.24%IONSIonis Pharmaceuticals$75.25-0.3%3.5394 of 5 stars2.86$99.35 32.0%21Trending NewsEarnings ReportAnalyst UpgradeAnalyst Revision3.19%CVACCureVac$4.66N/A1.80$6.83 46.6%5Negative News3.19%RNAAvidity Biosciences$12.91+0.3%1.3232 of 5 stars2.32$69.42 437.7%193.18%ARWRArrowhead Pharmaceuticals$74.93-1.9%2.6253 of 5 stars2.83$84.20 12.4%12News CoverageUpcoming Earnings2.95%ABUSArbutus Biopharma$4.40+0.1%0.9076 of 5 stars2.00$5.00 13.8%2Positive News2.59%DYNDyne Therapeutics$17.47-1.4%3.4622 of 5 stars2.94$35.14 101.2%17Analyst Downgrade2.10%SGMOSangamo Therapeutics$0.11-37.3%1.6848 of 5 stars1.75$5.50 4,837.2%4News CoverageUpcoming EarningsGap DownHigh Trading Volume1.84%STOKStoke Therapeutics$32.96-3.6%2.8396 of 5 stars2.92$41.83 26.9%12Upcoming Earnings1.52%PRQRProQR Therapeutics$1.63-0.6%3.3644 of 5 stars2.63$7.25 344.8%81.20%PEPGPepGen$1.93+7.2%2.7353 of 5 stars2.67$11.80 511.4%6 This page (NYSEARCA:MSGR) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Morningstar US Small Growth Please log in to your account or sign up in order to add this asset to your watchlist. Share Morningstar US Small Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
